| Date Filed | Type | Description |
| 10/11/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/02/2023 |
8-K
| Quarterly results |
| 08/16/2023 |
8-K
| Quarterly results |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/10/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 07/21/2023 |
8-K
| Quarterly results |
| 06/05/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 05/19/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 05/18/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/10/2023 |
8-K
| Quarterly results |
| 05/01/2023 |
10-K/A
| Annual Report for the period ended December 31, 2022 [amend] |
| 04/27/2023 |
8-K
| Quarterly results |
| 03/31/2023 |
4/A
| Dey Svetlana (Director) has filed a Form 4 on Bluejay Diagnostics, Inc.|
Txns:
| Bought 10,000 shares
@ $0.44, valued at
$4.4k
|
|
| 03/31/2023 |
4/A
| Dey Indranil (President and CEO) has filed a Form 4 on Bluejay Diagnostics, Inc.|
Txns:
| Bought 8,000 shares
@ $0.44, valued at
$3.5k
Bought 2,000 shares
@ $0.44, valued at
$880 |
|
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/24/2023 |
4
| Dey Svetlana (Director) has filed a Form 4 on Bluejay Diagnostics, Inc.|
Txns:
| Granted 10,000 shares
@ $0.44, valued at
$4.4k
|
|
| 03/20/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/20/2023 |
8-K
| Quarterly results |
| 03/16/2023 |
3
| Cook Jason (Chief Technology Officer) has filed a Form 3 on Bluejay Diagnostics, Inc. |
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/09/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/08/2022 |
8-K
| Quarterly results|
Docs:
|
"Bluejay Diagnostics, Inc. Reports Third Quarter 2022 Financial Results Acton, Massachusetts, October 25, 2022 – Bluejay Diagnostics, Inc. , a clinical-stage medical diagnostics company developing rapid, near-patient tests using whole blood on its Symphony platform to improve patient outcomes in critical care settings, today reported its financial results for the quarter and nine months ended September 30, 2022. “The last quarter focused on increasing awareness of Bluejay’ s Symphony IL-6 test by directly engaging the medical community to build a network of champions that will direct product development and drive initial commercialization,” said Neil Dey, CEO. “In August, Bluejay held a KOL event with clinicians in emergency and critical care who shared their perspectives on Symphony’ s pot..." |
|
| 10/28/2022 |
8-K
| Quarterly results |
| 09/07/2022 |
4
| Fisher Kenneth R (CFO) has filed a Form 4 on Bluejay Diagnostics, Inc.|
Txns:
| Bought 20,000 shares
@ $1.03, valued at
$20.6k
|
|
| 08/10/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 07/26/2022 |
8-K
| Quarterly results |
| 06/15/2022 |
8-K
| Quarterly results |
|